---
figid: PMC3154715__zh60081176510003
figlink: /pmc/articles/PMC3154715/figure/F3/
number: Fig. 3
caption: 'Working model of relaxin sustained-vasodilatory response. The precise localization
  of VEGF and PGF in the relaxin vasodilatory pathway is currently unknown, but two
  possibilities are depicted (?): relaxin may increase expression of angiogenic growth
  factor(s) in the arterial wall and/or release them from the extracellular matrix
  via MMP-9 or -2. Inhibitors of pregnancy- and/or relaxin-induced vasodilation are
  shown in the boxes. ET, endothelin; MMP, matrix metalloproteinase; ECM, extracellular
  matrix; RPF, renal plasma flow; GFR, glomerular filtration rate; RXFP, relaxin/insulin-like
  family peptide receptors; SU5416, vascular endothelial growth factor receptor tyrosine
  kinase inhibitor; GM6001, a general MMP inhibitor; cyclic CTT, a specific peptide
  inhibitor of MMP-2, cyclic CTTHWGFTLC; TIMP-2, tissue inhibitor of metalloproteinase;
  RES-701–1, a specific ETB receptor antagonist; SB209670, a mixed ETA and ETB receptor
  antagonist; l-NAME, NG-nitro-l-arginine methyl ester; l-NMMA, l-NG-monoethyl-arginine.
  Note that RXFP2 knockout (in mice), STT (control peptide for cyclic CTT), heat inactivated
  TIMP-2, BQ-123 (a specific ETA receptor antagonist), phosphoramidon (an inhibitor
  of the classical endothelin converting enzyme), d-NAME, and isotype-matched IgGs
  (controls for neutralizing antibodies) did not affect the sustained vasodilatory
  responses to relaxin. See text for details and supporting references. [Modified
  from McGuane JT, Danielson LA, Debrah JE, Rubin JP, Novak J, Conrad KP ()].'
pmcid: PMC3154715
papertitle: 'Maternal vasodilation in pregnancy: the emerging role of relaxin.'
reftext: Kirk P. Conrad. Am J Physiol Regul Integr Comp Physiol. 2011 Aug;301(2):R267-R275.
pmc_ranked_result_index: '220301'
pathway_score: 0.9060643
filename: zh60081176510003.jpg
figtitle: Working model of relaxin sustained-vasodilatory response
year: '2011'
organisms: Homo sapiens
ndex: f5fdabf0-df0e-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3154715__zh60081176510003.html
  '@type': Dataset
  description: 'Working model of relaxin sustained-vasodilatory response. The precise
    localization of VEGF and PGF in the relaxin vasodilatory pathway is currently
    unknown, but two possibilities are depicted (?): relaxin may increase expression
    of angiogenic growth factor(s) in the arterial wall and/or release them from the
    extracellular matrix via MMP-9 or -2. Inhibitors of pregnancy- and/or relaxin-induced
    vasodilation are shown in the boxes. ET, endothelin; MMP, matrix metalloproteinase;
    ECM, extracellular matrix; RPF, renal plasma flow; GFR, glomerular filtration
    rate; RXFP, relaxin/insulin-like family peptide receptors; SU5416, vascular endothelial
    growth factor receptor tyrosine kinase inhibitor; GM6001, a general MMP inhibitor;
    cyclic CTT, a specific peptide inhibitor of MMP-2, cyclic CTTHWGFTLC; TIMP-2,
    tissue inhibitor of metalloproteinase; RES-701–1, a specific ETB receptor antagonist;
    SB209670, a mixed ETA and ETB receptor antagonist; l-NAME, NG-nitro-l-arginine
    methyl ester; l-NMMA, l-NG-monoethyl-arginine. Note that RXFP2 knockout (in mice),
    STT (control peptide for cyclic CTT), heat inactivated TIMP-2, BQ-123 (a specific
    ETA receptor antagonist), phosphoramidon (an inhibitor of the classical endothelin
    converting enzyme), d-NAME, and isotype-matched IgGs (controls for neutralizing
    antibodies) did not affect the sustained vasodilatory responses to relaxin. See
    text for details and supporting references. [Modified from McGuane JT, Danielson
    LA, Debrah JE, Rubin JP, Novak J, Conrad KP ()].'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFB
  - RXFP1
  - VEGFC
  - TIMP2
  - PGF
  - MMP2
  - MMP9
  - CASP14
  - VEGFA
  - VEGFD
  - RAPGEF5
  - SB209670
genes:
- word: VEGF&PGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: RXFP1•
  symbol: RXFP1
  source: hgnc_symbol
  hgnc_symbol: RXFP1
  entrez: '59350'
- word: VEGF&PGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: TIMP-2
  symbol: TIMP2
  source: hgnc_symbol
  hgnc_symbol: TIMP2
  entrez: '7077'
- word: PGF
  symbol: PGF
  source: hgnc_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: MMP-2
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: VEGF&PGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: MMP-9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: mice
  symbol: MICE
  source: hgnc_alias_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: VEGF&PGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF&PGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: GFR
  symbol: GFR
  source: hgnc_alias_symbol
  hgnc_symbol: RAPGEF5
  entrez: '9771'
chemicals:
- word: SB209670
  source: MESH
  identifier: C087551
diseases: []
---
